TARDBP and proteostasis deficiencies: These findings have significant implications for the mechanisms of TDP-43 pathology formation and point to targeting the proteolysis of TDP-43 monomers and filaments as viable approaches for developing novel therapies to treat TDP-43 proteinopathies based on preventing TDP-43 aggregation, seeding activity, pathology formation and spreading.